Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fox News Host Gretchen Carlson to Emcee Lyme Research Alliance's “Time for Lyme” Gala
  • USA - English


News provided by

Lyme Research Alliance

Jan 13, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Gretchen Carlson learned first-hand the difficulties that countless people go through when not properly diagnosed with Lyme.
Gretchen Carlson learned first-hand the difficulties that countless people go through when not properly diagnosed with Lyme.

Stamford, CT (PRWEB) January 13, 2014 -- Lyme Research Alliance is pleased to announce that Fox News’ Gretchen Carlson will serve as the emcee for its annual “Time for Lyme” Gala, April 5, 2014, at the Hyatt Regency Greenwich in Old Greenwich, CT.

Carlson, who anchors and hosts the daytime program “The Real Story With Gretchen Carlson,” and most recently served as co-host of “FOX & Friends,” is not only a well-regarded television personality, but has been personally affected by Lyme disease, a bacterial infection transmitted by black-legged ticks.

She initially thought she was ill because she had 'been tired for 10 years with two kids and an early morning show that required me to get up every day at 3:45 a.m.'

Post this

The Greenwich, CT resident said she noticed last July 4 that she had a bulls-eye rash, a symptom commonly associated with Lyme, but a local physician told her it was not a “Lyme Disease” rash and Carlson was not treated.

But five or six weeks later she began experiencing “fever, horrendous headaches, night sweats, unbelievable exhaustion,” she said. Gretchen initially thought she had become ill because she had “been tired for 10 years with two kids and working on an early morning show that required me to get up every day at 3:45 a.m.” However, she remembered having had the rash and wondered if she did, indeed, have Lyme.

When another doctor who regularly appeared on her television show saw her one morning, he told her she didn’t look well. “When I told him my symptoms and that I had a rash, he said I had Lyme,” Carlson recalls. “So I went through all the tests and everything came back inconclusive which was frustrating. But I went on the prescribed drug for Lyme and started feeling better after a week or so.” Carlson remained on the antibiotic for 30 days and reports she is fine so far.

According to the Centers for Disease Control and Prevention (CDC), some 300,000 people in the U.S. are diagnosed with Lyme every year, making the illness a tremendous public health problem. It is the most commonly reported vector-borne illness in the U.S. and the epidemic is spreading worldwide.

“We’re thrilled and excited that Gretchen will be the emcee for our upcoming Gala. Not only is she a fabulous speaker with a dynamic personality, but she has learned first-hand the difficulties that countless people go through in terms of being diagnosed properly with Lyme,” said Debbie Siciliano, LRA’s co-president. “Sadly, each year hundreds of thousands go undiagnosed or misdiagnosed and are often told that their symptoms are all in their head. But if not diagnosed early, Lyme can affect every tissue in the body. That’s why there’s real urgency in developing a reliable diagnostic test and ultimately a cure for this disease.”

Carlson, who joined the Fox News Channel in 2005 and has since reported on major stories and conducted wide-ranging interviews, said she is looking forward to hosting LRA’s Gala and learning more about the research being directed to find answers to this tick-borne disease. “There seems to be so much more to learn about Lyme and so many more people are now affected that it is no longer just a regional problem,” she said. “I want answers to protect my children as well, since we live in Connecticut with high rates of the disease.”

LRA’s “Time for Lyme” Gala is the nonprofit’s largest fundraiser of the year and proceeds from it fund important medical research projects. LRA is the leading private funding organization for cutting-edge research into the prevention, diagnosis and treatment of Lyme and other tick-borne diseases by universities and major medical institutions in the U.S. In 2007, LRA partnered with Columbia University Medical Center in New York City and the Lyme Disease Association to endow the nation’s first Lyme and Tick-Borne Disease Research Center at Columbia.

The Gala will be held Saturday, April 5, from 6:30 p.m. to midnight at the Hyatt Regency Greenwich in Old Greenwich, CT. The evening features a cocktail reception, dinner, dancing, live auction and special celebrity guest appearances. For more information or to purchase tickets, visit http://www.LymeResearchAlliance.org and clicking on the homepage box, or by calling 203-969-1333.
______________________________________________________________________________
Lyme Research Alliance, formerly Time for Lyme, is a Connecticut-based, national non-profit that funds cutting-edge research into Lyme and other tick-borne diseases. For more information go to http://www.LymeResearchAlliance.org.

Peter Wild, Lyme Research Alliance, http://www.lymeresearchalliance.org, +1 203-448-8801, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.